A detailed history of Royal Bank Of Canada transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 528,688 shares of TEVA stock, worth $9.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
528,688
Previous 410,548 28.78%
Holding current value
$9.45 Million
Previous $5.79 Million 48.33%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $1.51 Million - $2.06 Million
118,140 Added 28.78%
528,688 $8.59 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $943,836 - $1.28 Million
88,457 Added 27.46%
410,548 $5.79 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $18,676 - $24,449
-2,300 Reduced 0.71%
322,091 $3.36 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $39,494 - $56,495
-5,280 Reduced 1.6%
324,391 $3.31 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $450,158 - $592,083
62,522 Added 23.4%
329,671 $2.48 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $84,745 - $115,257
10,137 Added 3.94%
267,149 $2.36 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $1.61 Million - $1.92 Million
-202,725 Reduced 44.1%
257,012 $2.34 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $436,021 - $759,542
63,560 Added 16.04%
459,737 $3.71 Million
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $4.05 Million - $5.7 Million
-548,244 Reduced 58.05%
396,177 $2.98 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $1.16 Million - $1.49 Million
-158,744 Reduced 14.39%
944,421 $8.87 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $975,578 - $1.26 Million
123,491 Added 12.61%
1,103,165 $8.84 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $2.04 Million - $2.48 Million
243,822 Added 33.13%
979,674 $9.54 Million
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $7.28 Million - $8.51 Million
735,852 New
735,852 $7.29 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.